Immune to Cancer: The CRI Blog
-
#AACR16 Update: The Promise of Synthetic Biology and CAR T Cell Technologies
Genetically engineered cells can be customized to target cancer.
-
Genetically Engineered CAR T Cells Prove Highly Effective Against Blood Cancers
The era of powerful, personalized medicine draws near.
-
Immunotherapy for Blood Cancers: What to Look for at the Upcoming ASH Meeting
Look for the latest results from trials of PD-1 inhibitors and new developments in adoptive cell transfer.
-
CAR T Cell Therapy Surges Forward
Researchers at the University of Pennsylvania publish latest results on an experimental immunotherapy using genetically engineered T…
-
Two Immunotherapies Clear Important Regulatory Hurdles
The anti-PD-1 drug nivolumab receives the go-ahead for use in Japan, while in the U.S., CAR-T cells…
-
Cancer Immunotherapy Goes Viral
A deadly virus that has killed more than 25 million people over the past 32 years has…